AU2001255320A1 - Secreted proteins - Google Patents
Secreted proteinsInfo
- Publication number
- AU2001255320A1 AU2001255320A1 AU2001255320A AU5532001A AU2001255320A1 AU 2001255320 A1 AU2001255320 A1 AU 2001255320A1 AU 2001255320 A AU2001255320 A AU 2001255320A AU 5532001 A AU5532001 A AU 5532001A AU 2001255320 A1 AU2001255320 A1 AU 2001255320A1
- Authority
- AU
- Australia
- Prior art keywords
- secreted proteins
- secreted
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19785400P | 2000-04-14 | 2000-04-14 | |
| US60/197,854 | 2000-04-14 | ||
| US20237300P | 2000-05-04 | 2000-05-04 | |
| US60/202,373 | 2000-05-04 | ||
| US20589900P | 2000-05-18 | 2000-05-18 | |
| US60/205,899 | 2000-05-18 | ||
| US20940100P | 2000-06-01 | 2000-06-01 | |
| US21015500P | 2000-06-01 | 2000-06-01 | |
| US60/209,401 | 2000-06-01 | ||
| US60/210,155 | 2000-06-01 | ||
| PCT/US2001/011861 WO2001079291A2 (en) | 2000-04-14 | 2001-04-11 | Secreted proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001255320A1 true AU2001255320A1 (en) | 2001-10-30 |
Family
ID=27539378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001255320A Abandoned AU2001255320A1 (en) | 2000-04-14 | 2001-04-11 | Secreted proteins |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20030215822A1 (en) |
| EP (1) | EP1328630A2 (en) |
| JP (1) | JP2004518402A (en) |
| AU (1) | AU2001255320A1 (en) |
| CA (1) | CA2405781A1 (en) |
| WO (1) | WO2001079291A2 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003520031A (en) * | 1999-11-12 | 2003-07-02 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 28 human secreted proteins |
| WO2001092495A2 (en) * | 2000-05-26 | 2001-12-06 | Millennium Pharmaceuticals, Inc. | A human lysyl ixodase (47765) and uses thereof |
| US20030114410A1 (en) | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| EP1445614A1 (en) * | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | A method for the in vitro assessment of the progression status of an HIV virus in an invidual |
| JP5435529B2 (en) | 2005-09-02 | 2014-03-05 | 東レ株式会社 | Composition and method for renal cancer diagnosis and prognosis prediction of renal cancer patients |
| CN110372795A (en) | 2007-08-02 | 2019-10-25 | 吉利德生物制剂公司 | LOX and LOXL2 inhibitor and its application |
| US20100021997A1 (en) * | 2008-02-21 | 2010-01-28 | Shahriar Koochekpour | Biologically active recombinant human saposin C and PSAP |
| WO2010080769A2 (en) | 2009-01-06 | 2010-07-15 | Arresto Biosciences, Inc. | Chemotherapeutic methods and compositions |
| RU2012110585A (en) * | 2009-08-21 | 2013-09-27 | Джилид Байолоджикс, Инк. | CATALYTIC DOMAINS OF LYSYLOXIDASE AND LOXL2 |
| BR112012008080A2 (en) * | 2009-08-21 | 2017-07-04 | Gilead Biologics Inc | in vivo screening assays. |
| RU2015108348A (en) * | 2010-02-04 | 2015-07-20 | Джилид Байолоджикс, Инк. | ANTIBODIES BINDING WITH LYSYLOXIDASE-LIKE ENZYME-2 (LOXL2), AND WAYS OF THEIR APPLICATION |
| CN116449030B (en) * | 2023-06-12 | 2023-08-15 | 天津德祥生物技术股份有限公司 | Method for cross-matching platelets |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6140056A (en) * | 1999-01-27 | 2000-10-31 | Millennium Pharmaceuticals, Inc. | MSP-18 protein and nucleic acid molecules and uses therefor |
| JP2002524025A (en) * | 1998-07-23 | 2002-08-06 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Human SBPSAPL gene with homology to the prosaposin family of neurotrophic factors |
-
2001
- 2001-04-11 JP JP2001576886A patent/JP2004518402A/en active Pending
- 2001-04-11 WO PCT/US2001/011861 patent/WO2001079291A2/en not_active Ceased
- 2001-04-11 AU AU2001255320A patent/AU2001255320A1/en not_active Abandoned
- 2001-04-11 CA CA002405781A patent/CA2405781A1/en not_active Abandoned
- 2001-04-11 EP EP01928467A patent/EP1328630A2/en not_active Withdrawn
- 2001-04-11 US US10/276,162 patent/US20030215822A1/en not_active Abandoned
-
2004
- 2004-11-30 US US11/002,844 patent/US20050079538A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001079291A3 (en) | 2003-05-01 |
| US20050079538A1 (en) | 2005-04-14 |
| JP2004518402A (en) | 2004-06-24 |
| WO2001079291A2 (en) | 2001-10-25 |
| US20030215822A1 (en) | 2003-11-20 |
| CA2405781A1 (en) | 2001-10-25 |
| EP1328630A2 (en) | 2003-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001271683A1 (en) | Novel secreted proteins | |
| AU2001280471A1 (en) | Novel secreted proteins and their uses | |
| AU2002233994A1 (en) | Secreted proteins | |
| AU2002361452A1 (en) | Secreted proteins | |
| AU2001270045A1 (en) | Secreted proteins | |
| AU2002353227A1 (en) | Secreted proteins | |
| AU2001227833A1 (en) | 71 human secreted proteins | |
| AU2002232596A1 (en) | Secreted human proteins | |
| AU2002342010A1 (en) | Secreted proteins | |
| AU2001255320A1 (en) | Secreted proteins | |
| AU2001237957A1 (en) | 17 human secreted proteins | |
| AU2002354803A1 (en) | Secreted proteins | |
| AU2002211220A1 (en) | Secreted proteins and their uses | |
| AU2002255733A1 (en) | Secreted proteins | |
| AU2002252700A1 (en) | Secreted proteins | |
| AU2001294719A1 (en) | Secreted human proteins | |
| AU2001290551A1 (en) | Secreted proteins and their uses | |
| AU2001229366A1 (en) | Secreted proteins | |
| AU2002236440A1 (en) | Novel secreted proteins and their uses | |
| AU2002327533A1 (en) | Secreted proteins | |
| AU2002258657A1 (en) | Secreted proteins | |
| AU2002239747A1 (en) | Cystoskeleton-associated proteins | |
| AU2001244863A1 (en) | Apoptin-associating protein | |
| AU2001229507A1 (en) | 21 human secreted proteins | |
| AU2390800A (en) | Secreted proteins |